Category : Seeking Alpha

Form 8.3 - Unite Group plc.

8.3

SUPCON Showcases Industrial AI Leadership at ADIPEC, Driving Intelligent Transformation

ABU DHABI, UAE, Nov. 7, 2025 /PRNewswire/ -- SUPCON(688777.SH, SUPCON.SW), a global provider of process automation and industrial AI solutions serving over 35,000 customers in more than 50 countries, is presenting its latest full-stack automation and...

Form 8.3 - Idox

8.3

Form 8.3 - Empiric Student Property Plc

8.3

California Approves Savvas Learning Company's Math Solutions for Statewide Adoption

New engaging, high-quality programs focus on real-world problem solving, bringing math learning to life PARAMUS, N.J., Nov. 7, 2025 /PRNewswire/ -- Savvas Learning Company, a next-generation learning solutions leader, is excited to announce that its...

Aktietilbagekøbsprogram

Den 23. oktober 2025 igangsatte Fast Ejendom Danmark A/S (”Selskabet”) et aktietilbagekøbsprogram.

Trading report Q3 2025 SKAKO A/S

Til Nasdaq Copenhagen A/S

Korrektion - Meddelelse vedrørende fusion af afdelinger under Investeringsforeningen Danske Invest

I fortsættelse af børsmeddelelse af 25. juni 2025 skal det for de nedenfor nævnte afdelinger/andelsklasser oplyses, at fusionen vil blive gennemført på basis af de anførte indre værdier og heraf beregnede ombytningsforhold.

Barrick Completes Sale of Alturas Project

All amounts expressed in U.S. dollars

InventHelp Inventor Develops Modified Smoke/Fire & CO Detector (CLR-333)

PITTSBURGH, Nov. 7, 2025 /PRNewswire/ -- "I'm an electrician, and I wanted to simplify the task of installing smoke/fire and CO detectors and ceiling lighting fixtures in any room," said an inventor, from Cicero¸ Ill., "so I invented the SAFETY LIGHT...

Relmada Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 13, 2025

CORAL GABLES, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system indications,...

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that...

Nexxen to Announce Third Quarter 2025 Financial Results on November 13, 2025

NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, will release its financial results for...

Holley Reports Third Quarter 2025 Results

THIRD CONSECUTIVE QUARTER OF CORE NET BUSINESS GROWTH

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

PHILADELPHIA and VANCOUVER, British Columbia, Nov. 07, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunother...